Sun XH - Search Results

1

TMEM16F may be a new therapeutic target for Alzheimer's disease.

Cui ZQ, Hu XY, Yang T, Guan JW, Gu Y, Li HY, Zhang HY, Xiao QH, Sun XH. Cui ZQ, et al. Among authors: sun xh. Neural Regen Res. 2023 Mar;18(3):643-651. doi: 10.4103/1673-5374.350211. Neural Regen Res. 2023. PMID: 36018189 Free PMC article.

2

Association between Alzheimer's disease pathogenesis and early demyelination and oligodendrocyte dysfunction.

Dong YX, Zhang HY, Li HY, Liu PH, Sui Y, Sun XH. Dong YX, et al. Among authors: sun xh. Neural Regen Res. 2018 May;13(5):908-914. doi: 10.4103/1673-5374.232486. Neural Regen Res. 2018. PMID: 29863022 Free PMC article.

3

Micro-RNA-137 Inhibits Tau Hyperphosphorylation in Alzheimer's Disease and Targets the CACNA1C Gene in Transgenic Mice and Human Neuroblastoma SH-SY5Y Cells.

Jiang Y, Xu B, Chen J, Sui Y, Ren L, Li J, Zhang H, Guo L, Sun X. Jiang Y, et al. Med Sci Monit. 2018 Aug 13;24:5635-5644. doi: 10.12659/MSM.908765. Med Sci Monit. 2018. PMID: 30102687 Free PMC article.

4

PPAR-α Agonist GW7647 Protects Against Oxidative Stress and Iron Deposit via GPx4 in a Transgenic Mouse Model of Alzheimer's Diseases.

Qu XX, He JH, Cui ZQ, Yang T, Sun XH. Qu XX, et al. Among authors: sun xh. ACS Chem Neurosci. 2022 Jan 19;13(2):207-216. doi: 10.1021/acschemneuro.1c00516. Epub 2021 Dec 29. ACS Chem Neurosci. 2022. PMID: 34965724

5

Mitochondrial Dysfunction in Parkinson's Disease: From Mechanistic Insights to Therapy.

Gao XY, Yang T, Gu Y, Sun XH. Gao XY, et al. Among authors: sun xh. Front Aging Neurosci. 2022 Jun 20;14:885500. doi: 10.3389/fnagi.2022.885500. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35795234 Free PMC article. Review.

6

Best medical management versus intravenous thrombolysis for mild non-disabling ischemic stroke: A prospective noninferiority registry study.

Cao X, Luo J, Xu B, Xiao Y, Yang T, Sun X, Sui Y. Cao X, et al. J Neurol Sci. 2023 Aug 15;451:120706. doi: 10.1016/j.jns.2023.120706. Epub 2023 Jun 17. J Neurol Sci. 2023. PMID: 37379725

7

Monocytes and Alzheimer's disease.

Feng Y, Li L, Sun XH. Feng Y, et al. Among authors: sun xh. Neurosci Bull. 2011 Apr;27(2):115-22. doi: 10.1007/s12264-011-1205-3. Neurosci Bull. 2011. PMID: 21441973 Free PMC article. Review.

8

Targeting CCR3 to Reduce Amyloid-β Production, Tau Hyperphosphorylation, and Synaptic Loss in a Mouse Model of Alzheimer's Disease.

Zhu C, Xu B, Sun X, Zhu Q, Sui Y. Zhu C, et al. Mol Neurobiol. 2017 Dec;54(10):7964-7978. doi: 10.1007/s12035-016-0269-5. Epub 2016 Nov 23. Mol Neurobiol. 2017. PMID: 27878757

9

The small molecular CCR3 antagonist YM344031 attenuates neurodegenerative pathologies and improves learning and memory performance in a mouse model of Alzheimer's disease.

Sui Y, Zhang Y, Dong C, Xu B, Sun X. Sui Y, et al. Brain Res. 2019 Sep 15;1719:1-10. doi: 10.1016/j.brainres.2019.05.022. Epub 2019 May 20. Brain Res. 2019. PMID: 31121157

10

Silencing of aquaporin1 activates the Wnt signaling pathway to improve cognitive function in a mouse model of Alzheimer's disease.

Yu B, Zhang J, Li H, Sun X. Yu B, et al. Gene. 2020 Sep 10;755:144904. doi: 10.1016/j.gene.2020.144904. Epub 2020 Jun 12. Gene. 2020. PMID: 32540373

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

710 results

Search Page

Filters